Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

IBT expects M&A activity to continue after Avidity takeover

(Sharecast News) - Shares in International Biotechnology Trust (IBT) were on the rise on Monday after Swiss pharma giant Novartis snapped up one of its portfolio companies for $12bn in cash. San Diego-based Avidity Biosciences, which specialising in RNA therapies for serious, genetic neuromuscular diseases, was IBT's eighth-largest holding in the medical investment group's quote portfolio, comprising 2.55% of the company's net asset value.

The acquisition was IBT's ninth M&A transaction involving a portfolio holding this year.

"By thinking like pharmaceutical business development departments, we have continued to successfully identify attractive acquisition targets, providing a substantial boost to shareholders' returns," said IBT portfolio managers Ailsa Craig and Marek Poszepczynski.

"With major pharmaceutical companies facing significant patent cliffs in the coming years, we expect this robust M&A environment to continue, providing further opportunities for IBT to take advantage."

Shares were up around 3% at 849.96p by 1358 GMT.

Share this article

Related Sharecast Articles

Sainsbury's said to have held merger talks with Morrisons
(Sharecast News) - Sainsbury's reportedly held talks this year with private equity-owned rival Morrisons over a potential multibillion-pound deal.
Galliford Try appointed to Constructing West Midlands plan
(Sharecast News) - Construction group Galliford Try announced on Monday that it has been appointed to a £3bn public sector building programme in the West Midlands.
MJ Gleeson CFO Stefan Allanson to step down
(Sharecast News) - Housebuilder MJ Gleeson said on Monday that chief financial officer Stefan Allanson plans to step down after 11 years in the role.
Lidl sales jump as pricing, promotions entice new customers
(Sharecast News) - Lidl's market share in the UK reached a record high in its most recent financial year, with the discount grocer reporting double-digit gains in sales and profits as price cuts and promotions brought more customers into its stores.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.